Prevalence of Multidrug-Resistant Tuberculosis and Associated Factors in Ethiopia: A Systematic Review

Journal of Pathogens
Solomon Weldegebreal AsgedomHailay Gebreyesus

Abstract

Multidrug-resistant tuberculosis (MDR-TB) has continued to be a challenge for tuberculosis (TB) control globally. Ethiopia is one of the countries with high MDR-TB burden. The main purpose of this study was to determine the prevalence of MDR-TB and associated factors in Ethiopia. A systematic review of the literatures on prevalence of MDR-TB and associated factors was conducted in the country. In our electronic search, 546 citations were depicted. Among the total 546 citations described, a total of 22 articles met eligibility criteria and were included in the review article. According to our review, the prevalence of MDR-TB ranged from 0 to 46.3%. The average mean rate of MDR-TB in Ethiopia was found to be 12.6 ± 15.9%. The overall prevalence of MDR-TB in all TB cases was estimated to be 1.4%. From a total of 3849 patients studied, 527 had MDR-TB. Previous exposure to antituberculosis treatment was the most commonly identified risk factor of MDR-TB in Ethiopia. Despite relative decline in incidence of MDR-TB, the distribution and prevalence of MDR-TB continued to be a serious challenge for TB control in Ethiopia. Previous exposure to antituberculosis treatment was also the most common risk factor for MDR-TB. Therefore, strong T...Continue Reading

References

Jan 6, 2001·Medicina clínica·L TorresJ Bautista García-Moya
Aug 30, 2008·BMJ : British Medical Journal·Alison GrantGuy Thwaites
Oct 3, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I Suárez-GarcíaA Noguerado-Asensio
Mar 17, 2009·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Masoud ShamaeiAli A Velayati
Mar 7, 2012·The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease·B TessemaA C Rodloff
May 12, 2012·BMC Research Notes·Gemeda AbebeRobert Colebunders
May 16, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Solomon Abebe YimerCarol Holm-Hansen
May 23, 2012·The Journal of International Medical Research·P ZhaoC Y Liu
Nov 13, 2013·Tuberculosis·Benson R KidenyaDaniel W Fitzgerald
Jul 1, 2015·African Health Sciences·Wondemagegn MuluBayeh Abera
Sep 4, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Girma MulisaGodana Jarso

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Software Mentioned

Google Scholar
HINARI
PubMed

Related Concepts

Related Feeds

Antitubercular Agents

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Antitubercular Agents (ASM)

Antitubercular agents are pharmacologic agents for treatment of tuberculosis. Discover the latest research on antitubercular agents here.

Related Papers

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
S Weldegebreal, T Mebrahtu
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Nino MdivaniHenry M Blumberg
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
W S LawC C Leung
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease
S ShinJ J Furin
© 2022 Meta ULC. All rights reserved